Clinical Trial: BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07872878) titled 'BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder' on Sept. 14.

Brief Summary: Bipolar disorder (BD) is often diagnosed 5 to 10 years after first symptoms, worsening prognosis. "Bipolar At-Risk" (BAR) criteria have been developed to identify people who may be in an early, prodromal stage of BD, but their long-term clinical course is not well characterized. BAROMETRE is a prospective, multicenter, naturalistic study following two groups of hospitalized psychiatric patients aged 18-65 for 36 months: patients meeting BAR criteria (without prior manic/hypomanic episode) and patients with an alre...